Delix Therapeutics is applying modern tools of pharmaceutical development to some of nature's most ancient therapies, psychedelics. Through its discovery platform, Delix has identified a new class of non-hallucinogenic versions of psychedelic compounds with favorable safety and therapeutic profiles. Delix is rapidly advancing these psychoplastogen compounds through preclinical and clinical development, with the goal of one day alleviating mental suffering through its FDA-approved, take-home medicines.
Location: United States, Massachusetts, Boston
Employees: 11-50
Total raised: $100M
Founded date: 2019
Investors 8
| Date | Name | Website |
| 18.10.2021 | Dolby Fami... | dolbyventu... |
| 04.10.2021 | RA Capital... | racap.com |
| 24.02.2022 | Audrey Cap... | audrey.co |
| - | Noetic Fun... | noeticfund... |
| - | PsyMed Ven... | psymed.ven... |
| - | OMX Ventur... | omx.vc |
| - | re.Mind Ca... | remind.vc |
| - | Axial VC | axialvc.co... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 10.01.2022 | - | $30M | - |
| 28.09.2021 | Series A | $70M | RA Capital... |
Mentions in press and media 17
| Date | Title | Description | Source |
| 13.12.2023 | Health | New psychedelic-like drugs: All treatment, no trip? | Since their creation decades ago, mind-altering drugs have remained as unchanged as bellbottoms, tie... | dailycamer... |
| 27.03.2023 | Here are the 15 hottest startups in the psychedelics industr... | From left: Sherry Rais, a cofounder and the CEO of Enthea; Mark Rus, the CEO of Delix Therapeutics; ... | businessin... |
| 22.11.2022 | Only a handful of psychedelics companies have gotten funding... | Andrew Levin is partner and managing director at VC firm RA Capital and interim CEO of Lusaris. RA C... | businessin... |
| 11.01.2022 | Delix Therapeutics Closes $30M Convertible Note Financing | Delix Therapeutics, a Boston MA-based neuroscience company developing novel disease-modifying therap... | finsmes.co... |
| 10.01.2022 | Delix Therapeutics Closes $30 Million Convertible Note Finan... | BOSTON, Jan. 10, 2022 /PRNewswire/ -- Delix Therapeutics (the "Company"), a neuroscience c... | marketscre... |
| 28.09.2021 | Delix Therapeutics Raises $70M in Series A Funding | Delix Therapeutics, a Boston MA-based preclinical neuroscience company, raised $70M in Series A fund... | finsmes.co... |
| 28.09.2021 | Delix Therapeutics closes $70M Series A | Delix Therapeutics has raised $70 million in a round co-led by Artis Ventures, RA Capital Management... | pitchbook.... |
| 28.09.2021 | Daily funding roundup - September 27, 2021 | Dice raised $122M; Delix Therapeutics landed $70M; Astera Labs secured $50M Dice: Dice is a London-... | vator.tv/n... |
| 27.09.2021 | Delix Therapeutics Closes $70 Million Series A Financing to ... | - | dolbyventu... |
| 27.09.2021 | Delix Therapeutics : Closes $70 Million Series A Financing t... | BOSTON, Sept. 27, 2021 /PRNewswire/ -- Preclinical neuroscience company Delix Therapeutics (the &quo... | marketscre... |
Show more